Search

everythinglearnresearchcommunity

for

Search:↓

Research 10 of 1000+

1. Comparing the risk of adverse pregnancy outcomes of Chinese patients with polycystic ovary syndrome with and without antiandrogenic pretreatment Fertility and Sterility · 2018 · 27 citations
2. A Randomized Cohort Study: Is It Worth the Time to Receive Antiandrogenic Pretreatment Before Ovulation Induction for Women With Polycystic Ovary Syndrome? Frontiers in Endocrinology · 2022 · 2 citations
3. Clinical effectiveness of ethinylestradiol-cyproterone acetate and raloxifene combination therapy in polycystic ovary syndrome-associated infertility American Journal of Translational Research · 2025
4. The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review The European Journal of Contraception & Reproductive Health Care · 2017 · 11 citations
5. Effectiveness of Low-dose Ethinylestradiol/Cyproterone Acetate and Ethinylestradiol/Desogestrel with and without Metformin on Hirsutism in Polycystic Ovary Syndrome: A Randomized, Double-blind, Triple-dummy Study. PubMed · 2020 · 5 citations
6. Combined oral contraceptives promote androgen receptor and oestrogen receptor alpha upregulation in the female prostate (Skene’s paraurethral glands) of adult gerbils (Meriones unguiculatus) Reproduction, Fertility and Development · 2018 · 3 citations
7. Polycystic ovary syndrome and estroprogestins Minerva Obstetrics and Gynecology · 2025
8. Evaluation of Risk-Minimization Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 µg: A Cross-Sectional Physician Survey Pharmaceutical medicine · 2017 · 12 citations
9. Prescribing of cyproterone acetate/ethinylestradiol in UK general practice: a retrospective descriptive study using The Health Improvement Network Contraception · 2016 · 6 citations
10. Prescription Appropriateness of Cyproterone Acetate/Ethinylestradiol in Primary Care: A Population-Based Study in Italy Clinical Drug Investigation · 2017 · 3 citations

Community

— no results